Submission hit rate: 50.0
Focus of research: tumor
Experience sharing: What is the situation, everyone?
Editor in Chief Decision Complete 26th Aug 22
Manuscript Decision complete 26th Aug 22
Editor Decision Complete 26th Aug 22
EIC Decision Started 24th Aug 22
Editor Review Completed 24th Aug 22
Waiting for Potential Reviewer Assignment 24th Aug 22
Monitoring Editor Assigned 24th Aug 22
Potential Monitoring Editor Assigned 24th Aug 22
Under Consideration 24th Aug 22
Editor Assigned 23rd Aug 22
Author Approved Converted Files 23rd Aug 22
Submission 23rd Aug 22

(0) 讚！ | 苍风己卯

I am wondering the same thing as you

(0) 讚！ | 努力啊大梦菲

What happened next?

(0) 讚！ | 努力啊大梦菲

My waiting for potential reviewer assignment turned into EIC Decision Started one day later

(0) 讚！ | 努力啊大梦菲

Usually cancer research only considers oncogene when rejected

(0) 讚！ | 小海宾吖

Review Speed: 3.0 | Submission Hit Rate: 50.0 Emphasis Research Area: Is there a chance 
Experience Sharing: EIC Decision Started 21st Aug 22Editor Review Completed 21st Aug 22Waiting for Potential Reviewer Assignment 17th Aug 22Monitoring Editor Assigned 17th Aug 22Potential Monitoring Editor Assigned 17th Aug 22Under Consideration 17th Aug 22Editor Assigned 9th Aug 22Author Approved Converted Files 9th Aug 22Submission 8th Aug 22

(0) 讚！ | 暴风玉华

It should not be on the same level

(0) 讚！ | 岭南鸿骞

How much does cancer research lag behind oncogene in tumor?

(0) 讚！ | 月河梓美

Heavy research focus: cancer biology
Sharing experience: Established journals, with somewhat lacking operation. Funding for cancer, in particular, is very competitive, with higher recognition than Molecular Cancer

(0) 讚！ | 小海宾吖

Have you found some reviewers?

(0) 讚！ | 岭南鸿骞

Magazines are not required, but reviewers may request them

(0) 讚！ | 九阴凌青

Do you require the original data to be uploaded?

(0) 讚！ | 风见秀丽

Do you need to upload the original data?

(0) 讚！ | 风见秀丽

Research focus: Tumor experience sharing: A well-established journal, but the quality of published articles in the past two years has been inconsistent, coupled with a certain degree of expansion, the Impact Factor may decrease slightly next year

(0) 讚！ | Lucy Larkin

Please log in to the submission system of Oncogene using the account of the corresponding author to access the links

(0) 讚！ | Ann Marion

Research focus: Oncology; Sharing experience on tumor metastasis: The impact factors for 2021 have come out, and I have seen a few have increased. How come it has gone down? If it goes up a little more, won't it pass 10? ?

(0) 讚！ | 九阴凌青

How is everything going from now on?

(0) 讚！ | Yves Meredith

Do you have to submit to figshare when submitting a manuscript?

(0) 讚！ | 上清怡萱

Review speed: 1.0 | Submission hit rate: 25.0
Experience sharing: Do we need to resubmit everything when revising? Will the previous status be cleared and turned into a new submission, not caused by my mistake. Please advise

(0) 讚！ | Jay Obadiah

How much is the non-OA page charge for the oncogene?

(0) 讚！ | 断刀艳清

Can someone share how multiple corresponding authors can link their ORCID in the submission system?

(0) 讚！ | 震雷效兰

Review speed: 2.0 | Submission hit rate: 5.0 Emphasis research directions: Oncology; Biology; Bioinformatics Experience sharing: Have you all chosen to publish OA? We all pay for the publication fees, right? Isn't it supposed to be an open market for external transactions?

(0) 讚！ | 德怀特伯特伦

How did your article end?

(0) 讚！ | 北斗敏才

Hello, is it the editor who decides during the second review of your article, or is it sent back to the previous reviewer?

(0) 讚！ | 震雷效兰

What happened later?

(0) 讚！ | 震雷效兰